Press Releases

Press Releases

Filters
Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division
Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of Directors
Viatris Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference
Viatris Announces Donations Totaling $1 Million to Provide Aid Supporting Access to Healthcare, Food Security and Water Stewardship
Viatris Announces Approval of Emissions Reduction Targets by the Science Based Target initiative (SBTi)
Viatris Completes Biosimilars Transaction with Biocon Biologics
Viatris Named U.S. In-House Legal Team of the Year for Intellectual Property Litigation by LMG Life Sciences
Viatris Wins Court Decision Invalidating AstraZeneca's Symbicort® Patent
Viatris Announces Two Acquisitions to Create What it Expects to be a Leading Ophthalmology Franchise; Plans to Provide Strategic Update on its February 2022 Investor Event
Viatris to Report Financial Results for the Third Quarter 2022 and Provide an Update on its February 28 Investor Event on November 7, 2022
Displaying 1 - 10 of 58